180 related articles for article (PubMed ID: 38814977)
1. Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning.
Elgedawy GA; Samir M; Elabd NS; Elsaid HH; Enar M; Salem RH; Montaser BA; AboShabaan HS; Seddik RM; El-Askaeri SM; Omar MM; Helal ML
PLoS One; 2024; 19(5):e0302977. PubMed ID: 38814977
[TBL] [Abstract][Full Text] [Related]
2. Metabolic predictors of COVID-19 mortality and severity: a survival analysis.
Abdallah AM; Doudin A; Sulaiman TO; Jamil O; Arif R; Sada FA; Yassine HM; Elrayess MA; Elzouki AN; Emara MM; Thillaiappan NB; Cyprian FS
Front Immunol; 2024; 15():1353903. PubMed ID: 38799469
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics study of COVID-19 patients in four different clinical stages.
Valdés A; Moreno LO; Rello SR; Orduña A; Bernardo D; Cifuentes A
Sci Rep; 2022 Jan; 12(1):1650. PubMed ID: 35102215
[TBL] [Abstract][Full Text] [Related]
4. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
Ansone L; Briviba M; Silamikelis I; Terentjeva A; Perkons I; Birzniece L; Rovite V; Rozentale B; Viksna L; Kolesova O; Klavins K; Klovins J
Microbiol Spectr; 2021 Dec; 9(3):e0033821. PubMed ID: 34878333
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.
Sindelar M; Stancliffe E; Schwaiger-Haber M; Anbukumar DS; Adkins-Travis K; Goss CW; O'Halloran JA; Mudd PA; Liu WC; Albrecht RA; García-Sastre A; Shriver LP; Patti GJ
Cell Rep Med; 2021 Aug; 2(8):100369. PubMed ID: 34308390
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients.
Marín-Corral J; Rodríguez-Morató J; Gomez-Gomez A; Pascual-Guardia S; Muñoz-Bermúdez R; Salazar-Degracia A; Pérez-Terán P; Restrepo MI; Khymenets O; Haro N; Masclans JR; Pozo OJ
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946479
[TBL] [Abstract][Full Text] [Related]
7. The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism.
Caterino M; Costanzo M; Fedele R; Cevenini A; Gelzo M; Di Minno A; Andolfo I; Capasso M; Russo R; Annunziata A; Calabrese C; Fiorentino G; D'Abbraccio M; Dell'Isola C; Fusco FM; Parrella R; Fabbrocini G; Gentile I; Castaldo G; Ruoppolo M
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502454
[TBL] [Abstract][Full Text] [Related]
8. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
D'Amora P; Silva IDCG; Budib MA; Ayache R; Silva RMS; Silva FC; Appel RM; Júnior SS; Pontes HBD; Alvarenga AC; Arima EC; Martins WG; Silva NLF; Diaz RS; Salzgeber MB; Palma AM; Evans SS; Nagourney RA
PLoS One; 2021; 16(12):e0259909. PubMed ID: 34851990
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment.
Rendeiro AF; Vorkas CK; Krumsiek J; Singh HK; Kapadia SN; Cappelli LV; Cacciapuoti MT; Inghirami G; Elemento O; Salvatore M
Front Immunol; 2021; 12():809937. PubMed ID: 35095900
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19.
Liu Y; Wu Y; Liu B; Zhang Y; San D; Chen Y; Zhou Y; Yu L; Zeng H; Zhou Y; Zhou F; Yang H; Yin L; Huang Y
Front Immunol; 2021; 12():677025. PubMed ID: 34504487
[TBL] [Abstract][Full Text] [Related]
11. Automated machine learning optimizes and accelerates predictive modeling from COVID-19 high throughput datasets.
Papoutsoglou G; Karaglani M; Lagani V; Thomson N; Røe OD; Tsamardinos I; Chatzaki E
Sci Rep; 2021 Jul; 11(1):15107. PubMed ID: 34302024
[TBL] [Abstract][Full Text] [Related]
12. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study.
Byeon SK; Madugundu AK; Garapati K; Ramarajan MG; Saraswat M; Kumar-M P; Hughes T; Shah R; Patnaik MM; Chia N; Ashrafzadeh-Kian S; Yao JD; Pritt BS; Cattaneo R; Salama ME; Zenka RM; Kipp BR; Grebe SKG; Singh RJ; Sadighi Akha AA; Algeciras-Schimnich A; Dasari S; Olson JE; Walsh JR; Venkatakrishnan AJ; Jenkinson G; O'Horo JC; Badley AD; Pandey A
Lancet Digit Health; 2022 Sep; 4(9):e632-e645. PubMed ID: 35835712
[TBL] [Abstract][Full Text] [Related]
13. Saliva metabolomic profile of COVID-19 patients associates with disease severity.
Saheb Sharif-Askari N; Soares NC; Mohamed HA; Saheb Sharif-Askari F; Alsayed HAH; Al-Hroub H; Salameh L; Osman RS; Mahboub B; Hamid Q; Semreen MH; Halwani R
Metabolomics; 2022 Oct; 18(11):81. PubMed ID: 36271948
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation.
Ceballos FC; Virseda-Berdices A; Resino S; Ryan P; Martínez-González O; Peréz-García F; Martin-Vicente M; Brochado-Kith O; Blancas R; Bartolome-Sánchez S; Vidal-Alcántara EJ; Albóniga-Díez OE; Cuadros-González J; Blanca-López N; Martínez I; Martinez-Acitores IR; Barbas C; Fernández-Rodríguez A; Jiménez-Sousa MÁ
Front Immunol; 2022; 13():925558. PubMed ID: 35844615
[TBL] [Abstract][Full Text] [Related]
15. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.
Roberts I; Wright Muelas M; Taylor JM; Davison AS; Xu Y; Grixti JM; Gotts N; Sorokin A; Goodacre R; Kell DB
Metabolomics; 2021 Dec; 18(1):6. PubMed ID: 34928464
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death.
Gisby J; Clarke CL; Medjeral-Thomas N; Malik TH; Papadaki A; Mortimer PM; Buang NB; Lewis S; Pereira M; Toulza F; Fagnano E; Mawhin MA; Dutton EE; Tapeng L; Richard AC; Kirk PD; Behmoaras J; Sandhu E; McAdoo SP; Prendecki MF; Pickering MC; Botto M; Willicombe M; Thomas DC; Peters JE
Elife; 2021 Mar; 10():. PubMed ID: 33704068
[TBL] [Abstract][Full Text] [Related]
17. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
Blasco H; Bessy C; Plantier L; Lefevre A; Piver E; Bernard L; Marlet J; Stefic K; Benz-de Bretagne I; Cannet P; Lumbu H; Morel T; Boulard P; Andres CR; Vourc'h P; Hérault O; Guillon A; Emond P
Sci Rep; 2020 Oct; 10(1):16824. PubMed ID: 33033346
[TBL] [Abstract][Full Text] [Related]
18. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
Shen B; Yi X; Sun Y; Bi X; Du J; Zhang C; Quan S; Zhang F; Sun R; Qian L; Ge W; Liu W; Liang S; Chen H; Zhang Y; Li J; Xu J; He Z; Chen B; Wang J; Yan H; Zheng Y; Wang D; Zhu J; Kong Z; Kang Z; Liang X; Ding X; Ruan G; Xiang N; Cai X; Gao H; Li L; Li S; Xiao Q; Lu T; Zhu Y; Liu H; Chen H; Guo T
Cell; 2020 Jul; 182(1):59-72.e15. PubMed ID: 32492406
[TBL] [Abstract][Full Text] [Related]
19. Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis.
Hu X; Wang J; Ju Y; Zhang X; Qimanguli W; Li C; Yue L; Tuohetaerbaike B; Li Y; Wen H; Zhang W; Chen C; Yang Y; Wang J; Chen F
BMC Infect Dis; 2022 Aug; 22(1):707. PubMed ID: 36008772
[TBL] [Abstract][Full Text] [Related]
20. Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort.
Wang H; Wang Y; Li X; Deng X; Kong Y; Wang W; Zhou Y
Cardiovasc Diabetol; 2022 Dec; 21(1):288. PubMed ID: 36564831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
